Pain News and Research

Latest Pain News and Research

Esperion Therapeutics reports positive results from ETC-1002 Phase 2a study for LDL-C treatment

Esperion Therapeutics, Inc., a clinical-stage biopharmaceutical company, today announced positive top-line results from a Phase 2a study of ETC-1002 when added to statin therapy in patients with elevated levels of low density lipoprotein cholesterol (LDL-C or "bad cholesterol").

4 Sep 2013

Researchers develop first animal model simulating eye complications linked with Graves' disease

Researchers have developed the first animal model simulating the eye complications associated with the thyroid condition Graves' disease, a breakthrough that could pave the way for better treatments, according to a recent study accepted for publication in The Endocrine Society's journal Endocrinology.

3 Sep 2013

New manual by psychologist explains basics of hypnotherapy

Hypnotic Relaxation Therapy: Principles and Applications (Springer Publishing) is a new training manual by Gary Elkins, Ph.D., director of the Mind-Body Medicine Research Laboratory at Baylor University.

3 Sep 2013

Facebook groups are effective tool for increasing HIV testing among at-risk populations

Peer-led Facebook groups are an acceptable and effective tool for increasing home-based HIV testing among at-risk populations. HIV infection is a major health concern for men who have sex with men (MSM), especially among African Americans and Latinos who have high rates of incident cases and new diagnoses.

3 Sep 2013

New prototype device for safe IV insertion reduces pain in hospitalized children

A new prototype device for rapid and safe IV insertion reduces pain in hospitalized children. The semi-automatic handheld device, called SAGIV, identifies veins, inserts a needle and withdraws it in a single movement. It was developed by students and clinicians in the Biodesign program of the Hebrew University of Jerusalem and Hadassah Medical Center.

3 Sep 2013

Drug for children with sickle cell anemia reduces hospitalizations and treatment costs

A drug proven effective for treatment of adults and children with sickle cell anemia reduced hospitalizations and cut annual estimated medical costs by 21 percent for affected infants and toddlers, according to an analysis led by St. Jude Children's Research Hospital. The report appears today in the advance online edition of the journal Pediatrics.

2 Sep 2013

Psychotherapist discovers effective behavioral psychology approach to treat relationship stress

Counselor Robert A. Moylan, LCPC has discovered through forty years of psychology research and life experience the simplest and most effective behavioral psychology approach currently available in the world to treat addictions, depression, anxiety, anger, trauma, and personality disorders. His book for adults, "Emotional Core Therapy" is currently the top rated book on Amazon.com in two different categories: "Mental Health" and "Emotions".

31 Aug 2013

Urbanrehab Pte opens additional physiotherapy clinic

Urbanrehab Pte Ltd, a practice that provides physiotherapy in Singapore as well as a variety of other related services, has just announced the opening of an additional physiotherapy clinic.

31 Aug 2013

Research roundup: Assessing new hospital observation rule; doctors' view of DNR orders for kids

Hospitalized patients in the United States are increasingly placed on "observation status." The Centers for Medicare & Medicaid Services (CMS) state that observation should rarely exceed 48 hours.

31 Aug 2013

Study describes lack of positive effects in drugs, long-term data and robust direct comparisons in RA

The German Institute for Quality and Efficiency in Health Care (IQWiG) examined 9 biotechnologically produced drugs for the treatment of adults with rheumatoid arthritis in whom prior pharmacological treatment had failed.

31 Aug 2013

Study shows functional MRI differences in working memory in people with primary insomnia

A new brain imaging study may help explain why people with insomnia often complain that they struggle to concentrate during the day even when objective evidence of a cognitive problem is lacking.

31 Aug 2013

Report sheds light on adolescents using illegal substances on an average day

On an average day, 881,684 teenagers aged 12 to 17 smoked cigarettes, according to a report by the Substance Abuse and Mental Health Services Administration (SAMHSA). The report also says that on an average day 646,707 adolescents smoked marijuana and 457,672 drank alcohol.

30 Aug 2013

Salford Royal consultant neurologist to launch largest study of pain in Parkinson's disease

Salford Royal Consultant Neurologist and University of Manchester academic Dr Monty Silverdale is to launch the largest ever study of pain in Parkinson's Disease.

30 Aug 2013

HSS, UCSF and Mayo Clinic to validate new MRI techniques, biomarkers for osteoarthritis treatment

In recent years, researchers have been frustrated because there are no tools to identify early stages of osteoarthritis and thus no good way to test therapies for preventing or slowing the disease. Now, three institutions have been awarded $1 million from the Arthritis Foundation to validate the use of new MRI (magnetic resonance imaging) techniques and newly identified biomarkers to solve this vexing problem.

30 Aug 2013

Stem cell researchers receive Early Translational research awards from CIRM

Four prominent researchers from UCLA's Eli & Edythe Broad Center of Regenerative Medicine and Stem Cell Research have received Early Translational research awards totaling approximately $13 million from the California Institute for Regenerative Medicine (CIRM) the state stem cell agency. The UCLA researchers received four of the 12 total awards; no other applicant institution received more than one award.

30 Aug 2013

Targeted Medical Pharma launches new division to manufacture and distribution dietary supplements

Targeted Medical Pharma, Inc., a biotechnology company that develops and distributes prescription medical foods to physicians and pharmacies, today announced the launch of a new division that will specialize in the manufacturing and distribution of a proprietary line of dietary supplements.

30 Aug 2013

Engaging in physical activity not going to put at greater risk of knee osteoarthritis

Adults age 45 and older who engaged in moderate physical activity up to two and a half hours a week did not increase their risk of developing knee osteoarthritis over a 6-year follow-up period, a new study finds.

29 Aug 2013

Mallinckrodt to present MNK-795 clinical data at PAINWeek 2013

Mallinckrodt announced today that the first clinical data on MNK-795 will be presented at PAINWeek 2013, to be held September 4-7 in Las Vegas. MNK-795 is an extended-release oral formulation of oxycodone and acetaminophen that has been studied in clinical trials for the management of moderate to severe acute pain where the use of an opioid analgesic is appropriate.

29 Aug 2013

Future of biomedical innovation depends on new trend for all players to work together for common goal

It's a long, expensive, risky road to turn a scientific breakthrough into a treatment that can help patients. Fewer organizations are trying to tackle the challenges alone, says a new paper from MIT researchers published August 28 in the journal Science Translational Medicine.

29 Aug 2013

Reformulated OxyContin®: an interview with Dr. Paul Coplan, Executive Director, Risk Management and Epidemiology, Purdue Pharma

OxyContin contains oxycodone, which is an opioid agonist. It is used for the management of moderate to severe pain when a constant opioid analgesic is needed for a prolonged period of time.

29 Aug 2013

Pain News and Research

Latest Pain News and Research

Esperion Therapeutics reports positive results from ETC-1002 Phase 2a study for LDL-C treatment

Researchers develop first animal model simulating eye complications linked with Graves' disease

New manual by psychologist explains basics of hypnotherapy

Facebook groups are effective tool for increasing HIV testing among at-risk populations

New prototype device for safe IV insertion reduces pain in hospitalized children

Drug for children with sickle cell anemia reduces hospitalizations and treatment costs

Psychotherapist discovers effective behavioral psychology approach to treat relationship stress

Urbanrehab Pte opens additional physiotherapy clinic

Research roundup: Assessing new hospital observation rule; doctors' view of DNR orders for kids

Study describes lack of positive effects in drugs, long-term data and robust direct comparisons in RA

Study shows functional MRI differences in working memory in people with primary insomnia

Report sheds light on adolescents using illegal substances on an average day

Salford Royal consultant neurologist to launch largest study of pain in Parkinson's disease

HSS, UCSF and Mayo Clinic to validate new MRI techniques, biomarkers for osteoarthritis treatment

Stem cell researchers receive Early Translational research awards from CIRM

Targeted Medical Pharma launches new division to manufacture and distribution dietary supplements

Engaging in physical activity not going to put at greater risk of knee osteoarthritis

Mallinckrodt to present MNK-795 clinical data at PAINWeek 2013

Future of biomedical innovation depends on new trend for all players to work together for common goal

Reformulated OxyContin®: an interview with Dr. Paul Coplan, Executive Director, Risk Management and Epidemiology, Purdue Pharma

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Pain News and Research

Latest Pain News and Research

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Newsletters you may be interested in